Pyomyositis: Difference between revisions
Line 23: | Line 23: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Age=== | |||
Pyomyositis is mainly a disease of children(2-5 yrs) but infection may occur in any age group. | |||
==Risk Factors== | ==Risk Factors== |
Revision as of 21:14, 15 August 2016
WikiDoc Resources for Pyomyositis |
Articles |
---|
Most recent articles on Pyomyositis Most cited articles on Pyomyositis |
Media |
Powerpoint slides on Pyomyositis |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Pyomyositis at Clinical Trials.gov Clinical Trials on Pyomyositis at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Pyomyositis
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Pyomyositis Discussion groups on Pyomyositis Patient Handouts on Pyomyositis Directions to Hospitals Treating Pyomyositis Risk calculators and risk factors for Pyomyositis
|
Healthcare Provider Resources |
Causes & Risk Factors for Pyomyositis |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
Synonyms and keywords: Tropical pyomyositis; Myositis tropicans; Bungpagga; Lambo lambo
Overview
Pyomyositis, also known as tropical pyomyositis or myositis tropicans is a bacterial infection of the skeletal muscles which results in a pus-filled abscess. Pyomyositis is more common in tropical areas but can also occur in the temperate zones. Pyomyositis is most often caused by the bacterium Staphylococcus aureus.[1] The infection can affect any skeletal muscle, but most often infects the large muscle groups such as the quadriceps or gluteal muscles. In tropical regions, the infection often follows minor trauma, while in temperate zones the infection typically occurs in people with immune deficiencies. The abscess within the muscle is drained surgically and antibiotics are administered to fully clear the infection.
Historical Perspective
Pyomyositis is first described by Scriba in 1885.
Classification
Pyomyositis may be classified according to international classification of diseases-10(ICD-10) into
- M60.0 Infectious myositis, Tropical pyomyositis (optionally, B95-B97 to indicate the infectious agent; B95.6 for Staphylococcus aureus)[2][3]
Pathophysiology
Causes
Differentiating Pyomyositis from Other Diseases
Epidemiology and Demographics
Age
Pyomyositis is mainly a disease of children(2-5 yrs) but infection may occur in any age group.
Risk Factors
Screening
Natural History, Complications, and Prognosis
Natural History
Complications
Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
- Pyomyositis[4]
- Preferred regimen (3): Cefazolin 2 g IV q8h (if MSSA)
- Alternate regimen: Vancomycin 1 g IV q12h (if MRSA)
Surgery
Prevention
References
- ↑ Chauhan, S.; Jain, S.; Varma, S.; Chauhan, SS. (2004). "Tropical pyomyositis (myositis tropicans): current perspective". Postgrad Med J. 80 (943): 267–70. PMID 15138315. Unknown parameter
|month=
ignored (help) - ↑ Wikipedia(2016). https://en.wikipedia.org/wiki/Pyomyositis Accessed on August 15,2016
- ↑ Wikipedia(2016).https://de.wikipedia.org/wiki/Pyomyositis Accessed on August 15,2016
- ↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.